Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $16.8900 (0.3%) ($16.8900 - $16.8900) on Fri. Mar. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.64% (three month average) | RSI | 46 | Latest Price | $16.8900(0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.32% in a week (0% probabilities). VIXM(-34%) VXX(-27%) IGOV(-15%) UNG(-11%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.32% (StdDev 2.64%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.99 | 5 Day Moving Average | $16.64(1.5%) | 10 Day Moving Average | $16.51(2.3%) | 20 Day Moving Average | $16.99(-0.59%) | To recent high | -28% | To recent low | 6.9% | Market Cap | $1.255b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |